Summary & Overview
CPT 87267: Enterovirus Antigen Detection by Direct Fluorescent Antibody
CPT code 87267 represents a direct fluorescent antibody (DFA) laboratory test used to detect enterovirus antigens in patient specimens. As a targeted virology diagnostic, this code supports clinical decision-making for suspected enteroviral infections and can influence infection control, antiviral management, and patient disposition. Nationally, accurate laboratory coding for antigen detection affects claims processing, lab utilization reporting, and public health surveillance.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find concise benchmarks for utilization and billing context, clinical background on the DFA method for enterovirus detection, common coding and billing considerations, and an overview of how this service is typically delivered across laboratory and hospital settings. The publication highlights operational factors relevant to labs and billing teams, and summarizes typical sites of service and service type.
Data not available in the input for specific payor rates, taxonomies, ICD-10 crosswalks, and related codes is noted where applicable.
Billing Code Overview
CPT code 87267 describes a laboratory test in which a lab analyst performs a direct fluorescent antibody (DFA) assay to detect enterovirus antigens. This service is a microbiology/virology diagnostic test that identifies viral antigens in clinical specimens using fluorescently labeled antibodies and direct microscopy.
Service Type: Laboratory — Microbiology/Virology, Direct Fluorescent Antibody Test
Typical Site of Service: Clinical laboratory or hospital laboratory
Clinical & Coding Specifications
Clinical Context
A pediatric patient presents to the urgent care clinic with fever, irritability, and signs of viral meningitis including headache and neck stiffness. Cerebrospinal fluid (CSF) is obtained via lumbar puncture in the emergency department. The laboratory performs a direct fluorescent antibody (DFA) test to detect enterovirus antigens on the CSF specimen. Results are used to support rapid diagnosis of enteroviral infection and help guide isolation, antiviral therapy considerations, and disposition. Typical workflow: specimen collection and transport to the microbiology/virology laboratory; receipt and accessioning; preparation of CSF smear; application of fluorescein-labeled enterovirus-specific antibodies; incubation, washing, and fluorescent microscopy reading by a qualified lab analyst; documentation of result in the laboratory information system and reporting to the ordering clinician.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing only the professional interpretation component separate from the technical component. |
59 | Distinct procedural service | Use when the DFA test is reported with another lab test on the same date and services are distinct and separate. |
90 | Reference (outside) laboratory | Use when the specimen is analyzed by an outside reference laboratory and the provider is reporting that external service. |
TC | Technical component | Use when billing only the technical component (equipment, supplies, and technician work) of the DFA test. |
QX | Relationship – assistant at surgery | Not typically applicable but included when an assistant performs an allowable portion of a procedure in settings that permit billing with lab oversight (rare for this code). |
QY | Anesthesia managed by an anesthesiologist | Not applicable to laboratory testing; excluded in most claims but retained for comprehensive modifier relevance. |
11 | Default/normal processing | Use when services are performed in the routine manner without unusual circumstances. |
22 | Increased procedural services | Use when the DFA test requires substantially greater work or complexity than typical (documented justification required). |
52 | Reduced services | Use when the test is partially reduced or not completed as originally planned. |
90 | Reference (outside) laboratory | Use when test performed by an independent external lab and reported by the billing facility. |
| Taxonomy Code | Specialty | Notes |
|---|---|---|
| 207Q00000X | Anatomic Pathology | Pathologists or laboratory directors overseeing diagnostic virology services. |
| LABS00000X | Clinical Laboratory | Medical technologists and laboratory directors performing or supervising DFA testing. |
| 207L00000X | Clinical Pathology | Physicians with clinical pathology specialty involved in test interpretation. |
| 170100000X | Infectious Disease | Infectious disease physicians ordering and acting on enterovirus DFA results. |
Related Diagnoses
| ICD-10 Code | Description | Clinical Relevance |
|---|---|---|
A87.9 | Viral meningitis, unspecified | Enterovirus is a common cause of viral meningitis; DFA on CSF supports this diagnosis. |
B34.2 | Enterovirus infection, unspecified | Direct testing for enteroviral antigen detects enterovirus in relevant specimens. |
G02.9 | Meningitis in infectious and parasitic disease classified elsewhere, unspecified | Used when meningitis is attributed to a systemic infectious agent like enterovirus. |
R50.9 | Fever, unspecified | Fever is a common presenting symptom prompting CSF testing for enterovirus. |
R51 | Headache | Severe headache with meningeal signs may trigger lumbar puncture and enterovirus testing. |
J06.9 | Acute upper respiratory infection, unspecified | Enterovirus can present with respiratory symptoms; DFA may be used on respiratory specimens depending on clinical presentation. |
A08.9 | Viral intestinal infection, unspecified | Enteroviruses can cause gastrointestinal symptoms; antigen testing may be relevant for stool or other specimens. |
Related CPT Codes
| CPT Code | Description | Relationship to This Procedure |
|---|---|---|
87265 | Infectious agent detection by immunofluorescent technique, viral antigen, other than enterovirus (single step) | Alternative DFA immunofluorescent tests for other viral antigens; used when testing for non-enteroviral causes. |
87480 | Infectious agent antigen detection by immunoassay for respiratory syncytial virus (RSV) | Common parallel rapid viral antigen testing performed on respiratory specimens when broader viral evaluation is needed. |
87631 | Infectious agent detection by nucleic acid (DNA or RNA); enterovirus, amplified probe technique | Molecular PCR-based enterovirus testing often performed alongside or following DFA for higher sensitivity and confirmation. |
99000 | Handling and/or conveyance of specimen for transfer to another laboratory (if applicable) | Administrative/handling code used when specimens are sent out for reference testing when in-house DFA is not performed. |
87070 | Culture, bacterial; any source, other than blood, aerobic, with isolation and presumptive identification of isolates | Microbiologic cultures that may be ordered concurrently to evaluate for bacterial meningitis in suspected CNS infections. |